Lundbäck T

Targeting TUBG1 in RB1-negative tumors.

Lindström L, Zhou J, Villoutreix BO, ..., Olsson R, Alvarado-Kristensson M

FASEB J. 39 (5) e70431 [2025-03-15; online 2025-02-28]

Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound.

Giovannucci TA, Salomons FA, Haraldsson M, ..., Johnsen JI, Dantuma NP

Cell Death Dis 12 (10) 914 [2021-10-06; online 2021-10-06]

Development of a chemical probe against NUDT15.

Zhang SM, Desroses M, Hagenkort A, ..., Stenmark P, Helleday T

Nat. Chem. Biol. 16 (10) 1120-1128 [2020-10-00; online 2020-07-20]

Synthesis, Evaluation and Proposed Binding Pose of Substituted Spiro-Oxindole Dihydroquinazolinones as IRAP Inhibitors.

Engen K, Vanga SR, Lundbäck T, ..., Larhed M, Rosenström U

ChemistryOpen 9 (3) 325-337 [2020-03-00; online 2020-03-02]

Perspective on CETSA Literature: Toward More Quantitative Data Interpretation.

Seashore-Ludlow B, Axelsson H, Lundbäck T

SLAS Discov 25 (2) 118-126 [2020-02-00; online 2019-10-30]

In Silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization

Michel M, Homan EJ, Wiita E, ..., Helleday T, Berglund UW

- - (-) - [2019-10-25; online 2019-10-25]

A Phenotypic Screening Assay Identifies Modulators of Diamond Blackfan Anemia.

Siva K, Ek F, Chen J, ..., Lundbäck T, Flygare J

SLAS Discov 24 (3) 304-313 [2019-03-00; online 2019-02-21]

Quantitative Interpretation of Intracellular Drug Binding and Kinetics Using the Cellular Thermal Shift Assay.

Seashore-Ludlow B, Axelsson H, Almqvist H, ..., Jonsson M, Lundbäck T

Biochemistry 57 (48) 6715-6725 [2018-12-04; online 2018-11-19]